This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Best Practices in Meningococcal B Disease Prevention

Best Practices in Meningococcal B Disease Prevention

Format

Roundtable

Time to Complete

1.25 hours

Released

March 31, 2018

Expires

March 31, 2019
Add to Queue


Maximum Credits

1.25 / AMA PRA Category 1 CreditsTM
1.25 / AMA PRA Category 1 CreditsTM   + 1.25 AAFP Prescribed Credit
1.25 / AMA PRA Category 1 CreditsTM   + 1.25 AAP Credit
1.25 / CNE Contact Hours

Accredited Provider



Provided by Boston University School of Medicine

Commercial Supporter

This activity is supported by an independent educational grant from Pfizer Inc.

Program Description

Meningococcal disease, specifically serotype B (MenB), is an ongoing problem in this country, particularly in light of recent university outbreaks. The disease can develop from initial symptoms to death within 24 hours, and as many as 20% of survivors have permanent sequelae. Notably, incidence rates are often a misconception due to underdetection and under-reporting. Given how disabling diseases can be that could have been prevented with vaccination, it is essential that healthcare workers delivering vaccinations enhance their standards of care in practice in order to deliver the highest rates of preventative care. The goal of the activity is to improve comprehension and initiate practice changes so as to improve immunization rates for all patients who are currently scheduled for the MenB vaccination.

Intended Audience

The target audience includes pediatricians, family practitioners, nurses, and other clinicians who specialize in adolescent health, college health, and immunization who care for patients who are scheduled to receive the MenB vaccine.

Educational Objectives

Upon completion of these activities, participants should be better able to:

  • Discuss the current epidemiology of MenB in the United States and the profiles of patients at greatest risk for this vaccine-preventable disease
  • Describe recent MenB immunization recommendations made by the Advisory Committee on Immunization Practices (ACIP) and the rationale behind a category B classification
  • Examine the mechanism of action, contraindications, and adverse effect profiles of current MenB vaccines
  • Given a patient case, recognize best practices in counseling patients and their parents/caregivers on the importance of administering the MenB vaccine
  • Discuss practice considerations for administering the MenB vaccine such as documentation, billing, and screening for additional immunizations

Conflict Of Interest Disclosure Policy

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Faculty

SPEAKERS
Stephen I. Pelton, MD, Course Director

Professor of Pediatrics - Boston University School of Medicine
Professor of Epidemiology
Boston University School of Public Health
Director, Section of Pediatric Infectious Diseases
Boston Medical Center
Boston, MA

Dr. Pelton receives Grant/Research/Clinical Trial Support from Pfizer, Merck, and Cempra. He is a Consultant for Pfizer, GSK, Sanofi, and Sequiris.

Gary Marshall, MD
Professor of Pediatrics,
Chief, Division of Pediatric Infectious Diseases
University of Louisville School of Medicine
Louisville, KY

Dr. Marshall is an investigator on clinical trials funded by GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi Pasteur, and Seqirus, and has also has received honoraria from these companies for service on advisory boards.
He has also received honoraria from Pfizer and Sanofi for non-branded presentations.

Carole Moloney, RN, MSN, CPNP
Clinical Instructor of Pediatrics
Boston University School of Medicine
Pediatric Infectious Diseases - Boston Medical Center
Boston, MA

Ms. Moloney is a speaker for Sanofi Pasteur.

Planning Committee

Henry Bernstein, DO, MHCM, FAAP, Course Co-Director
Professor of Pediatrics
Zucker School of Medicine at Hofstra/Northwell Cohen Children’s Medical Center
New Hyde Park, NY

Dr. Bernstein has no relevant financial relationships to disclose.

Jennifer Beck, MD
Hospitalist and AAFP Member
Baptist Health
Lexington, KY

Dr. Beck has no relevant financial relationships to disclose.

Carmela Townsend, DNP, MS/MBA, RN, has no relevant financial relationships to disclose.

Accredited Provider Disclosure

Ms. Townsend, DNP, MS/MBA, RN, has no relevant financial relationships to disclose.

Elizabeth Drury, Dana Frazier, and Julie White of the planning committee have no relevant financial relationships to disclose.

Publishing Staff Disclosure

Chris Drury, medical writer, has no relevant financial relationships to disclose.

Credit

1.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Boston University School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.25

Type

CNE Contact Hour(s)

Accreditation Statement

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This activity provides 1.25 Contact Hours.

Credit

1.25

Type

AMA PRA Category 1 Credit(s)TM
AAFP Prescribed Credit

Accreditation Statement

This Enduring Material activity, Best Practices in Meningococcal B Disease Prevention, has been reviewed and is acceptable for up to 1.25 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 03/30/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Designation Statement

This activity provides 1.25 Prescribed credits.

Credit

1.25

Type

AMA PRA Category 1 Credit(s)TM
AAP Credit

Accreditation Statement

AMA PRA Category 1 Credit(s)TM
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AAP Credit
This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.25 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Designation Statement

AMA PRA Category 1 Credit(s)TM
Boston University School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAP Credit
This activity provides 1.25 AAP credits.

Disclosure of Unlabeled Use

There is no off-label discussion in the presentation.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

Instructions

In order to successfully complete this activity, you are required to view the webcast and complete all test questions and evaluation. CME/CNE/AAFP/AAP credit will be awarded provided a score of 70% or better is achieved. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For any CME or CNE accreditation questions please email the BUSM CME office at cme@bu.edu.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue